WO2007136250A3 - A pharmaceutical composition suitable for the treatment of cancer and method of preparing said pharmaceutical composition - Google Patents
A pharmaceutical composition suitable for the treatment of cancer and method of preparing said pharmaceutical composition Download PDFInfo
- Publication number
- WO2007136250A3 WO2007136250A3 PCT/NL2007/000135 NL2007000135W WO2007136250A3 WO 2007136250 A3 WO2007136250 A3 WO 2007136250A3 NL 2007000135 W NL2007000135 W NL 2007000135W WO 2007136250 A3 WO2007136250 A3 WO 2007136250A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pharmaceutical composition
- cancer
- preparing
- treatment
- composition suitable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a pharmaceutical composition com- prising an inhibitor of the enzyme 7-dehydrocholesterol reductase (DHCR7) together with a pharmaceutically acceptable carrier or ex- cipient. This pharmaceutical composition is active against various types of cancer, in particular but not limited to adenocarcinomas of the upper gastro-intestinal tract. The invention also relates to a method of preparing a pharmaceutical composition suitable for the treatment of an adenocarcinoma.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL1031872 | 2006-05-24 | ||
NL1031872 | 2006-05-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007136250A2 WO2007136250A2 (en) | 2007-11-29 |
WO2007136250A3 true WO2007136250A3 (en) | 2008-03-20 |
Family
ID=38662919
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/NL2007/000135 WO2007136250A2 (en) | 2006-05-24 | 2007-05-24 | A pharmaceutical composition suitable for the treatment of cancer and method of preparing said pharmaceutical composition |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007136250A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10548908B2 (en) * | 2016-09-15 | 2020-02-04 | Nostopharma, LLC | Compositions and methods for preventing and treating heterotopic ossification and pathologic calcification |
WO2023086671A1 (en) * | 2021-11-15 | 2023-05-19 | The Broad Institute, Inc. | Compounds, compositions, and methods for inducing antimicrobial intracellular activity and for preventing and treating microbial infections |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002030462A2 (en) * | 2000-10-13 | 2002-04-18 | Curis, Inc. | Hedgehog antagonists, methods and uses related thereto |
WO2004026304A1 (en) * | 2002-09-17 | 2004-04-01 | Medical Research Council | An inhibitor of the shh signalling patway and a testosterone supressing agent for the treatment of cancer |
WO2006031977A2 (en) * | 2004-09-13 | 2006-03-23 | The Regents Of The University Of California | Inhibition of pancreatic cancer cell growth |
-
2007
- 2007-05-24 WO PCT/NL2007/000135 patent/WO2007136250A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002030462A2 (en) * | 2000-10-13 | 2002-04-18 | Curis, Inc. | Hedgehog antagonists, methods and uses related thereto |
WO2004026304A1 (en) * | 2002-09-17 | 2004-04-01 | Medical Research Council | An inhibitor of the shh signalling patway and a testosterone supressing agent for the treatment of cancer |
WO2006031977A2 (en) * | 2004-09-13 | 2006-03-23 | The Regents Of The University Of California | Inhibition of pancreatic cancer cell growth |
Non-Patent Citations (2)
Title |
---|
KOIDE TETSUYA ET AL: "Negative regulation of Hedgehog signaling by the cholesterogenic enzyme 7-dehydrocholesterol reductase", DEVELOPMENT (CAMBRIDGE), vol. 133, no. 12, 10 May 2006 (2006-05-10), online publication, pages 2395 - 2405, XP002464601, ISSN: 0950-1991 * |
TOKAR E J ET AL: "Vitamin D3 inhibits growth, matrix metalloproteinase activity (MMP) and invasion by RWPE2-W99 human prostate carcinoma cells", CLINICAL & EXPERIMENTAL METASTASIS, XX, XX, vol. 21, no. 7, February 2004 (2004-02-01), pages 607 - 608, XP009094492, ISSN: 0262-0898 * |
Also Published As
Publication number | Publication date |
---|---|
WO2007136250A2 (en) | 2007-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008124085A3 (en) | Methods of using combinations of mek and jak-2 inhibitors | |
WO2009027644A3 (en) | Compositions for the treatment of neoplastic diseases | |
WO2007106537A3 (en) | Aminoquinolones as gsk-3 inhibitors | |
WO2003043631A3 (en) | Method for identification of tumor targeting enzymes | |
WO2007100895A3 (en) | Cancer treatment with gamma-secretase inhibitors | |
WO2006096173A8 (en) | Pharmaceutical compositions and methods for peptide treatment | |
WO2008039829A3 (en) | Diphenylheterocycle cholesterol absorption inhibitors | |
WO2006045119A3 (en) | Improved inhibitors for the soluble epoxide hydrolase | |
WO2007111866A3 (en) | Combinations of hcv protease inhibitor(s) and cyp3a4 inhibitor(s), and methods of treatment related thereto | |
WO2008112565A3 (en) | Method and composition for treating cancer | |
WO2007146426A3 (en) | Nanoshells for drug delivery | |
WO2011031474A3 (en) | Use of metformin in cancer treatment and prevention | |
WO2006037981A8 (en) | Inhibition of tumour cell migration | |
WO2006063055A3 (en) | Enzyme conjugates for use as detoxifying agents | |
WO2005105094A3 (en) | Cancer treatment method | |
WO2008022345A3 (en) | Compositions and methods for inhibiting cytochrome p450 | |
WO2007144169A3 (en) | Entacapone-derivatives | |
AU2003300368A1 (en) | Methods and compositions for the diagnosis, prognosis, and treatment of cancer | |
WO2008011603A3 (en) | Modulating notch1 signaling pathway for treating neuroendocrine tumors | |
WO2007121088A3 (en) | Combinations of therapeutic agents for treating cancer | |
WO2007084661A3 (en) | Therapy-enhancing glucan | |
WO2008034796A3 (en) | Estratriene derivatives and their uses as 17beta-hydr0xyster0id dehydrogenase inhibitors | |
WO2008013966A3 (en) | Use of 8-quinolinol and its analogs to target cancer stem cells | |
WO2007146335A3 (en) | Compounds and compositions for treatment of cancer | |
WO2005107753A3 (en) | Naltrexone long acting formulations and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07747317 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07747317 Country of ref document: EP Kind code of ref document: A2 |